Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 USD | +1.59% | +3.92% | +25.64% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
Sales 2024 * | 376M 30.11B | Sales 2025 * | 445M 35.65B | Capitalization | 2.23B 179B |
---|---|---|---|---|---|
Net income 2024 * | 38M 3.04B | Net income 2025 * | 51M 4.08B | EV / Sales 2024 * | 5.15 x |
Net cash position 2024 * | 298M 23.87B | Net cash position 2025 * | 426M 34.13B | EV / Sales 2025 * | 4.06 x |
P/E ratio 2024 * |
68.3
x | P/E ratio 2025 * |
45.8
x | Employees | 1,008 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 44.13% |
Latest transcript on Cellebrite DI Ltd.
1 day | +1.59% | ||
1 week | +3.92% | ||
Current month | -1.81% | ||
1 month | -4.98% | ||
3 months | +17.62% | ||
6 months | +68.68% | ||
Current year | +25.64% |
Managers | Title | Age | Since |
---|---|---|---|
Yossi Carmil
CEO | Chief Executive Officer | 57 | 31/12/03 |
Dana Gerner
DFI | Director of Finance/CFO | 56 | 06/05/14 |
Ayala Shapira
CMP | Compliance Officer | 53 | 02/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Clammer
BRD | Director/Board Member | 53 | 29/08/21 |
Thomas Hogan
CHM | Chairman | 64 | 07/08/23 |
Dafna Gruber
BRD | Director/Board Member | 58 | 29/08/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 7 M€ | +1.95% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 10.88 | +1.59% | 429,966 |
25/04/24 | 10.71 | 0.00% | 456,417 |
24/04/24 | 10.71 | 0.00% | 460,786 |
23/04/24 | 10.71 | +2.29% | 490,387 |
22/04/24 | 10.47 | 0.00% | 385,937 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.64% | 2.23B | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.55B | |
+17.75% | 41.41B | |
+55.21% | 35.63B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- CLBT Stock